Kadcyla 160 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XTA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $41,372
Award facts
- Contract value 100% obligated
- $41,372.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $41,372.16 to DMS Pharmaceutical Group Inc. for the supply of 160 mg vials of Kadcyla, an oncology treatment medication. The contract was awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, and will be performed at the awardee's facilities in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its woman-owned small business status.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in SAM.gov since 2001, serves as a critical supplier within the federal pharmaceutical supply chain. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026, which provides the framework for issuing delivery orders such as this one. DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide, with a demonstrated portfolio of federal contracts covering oncology treatments, vaccines, and specialty pharmaceutical products.
Quick answers
Who was awarded contract SPE2DX25F6XTA?
SPE2DX25F6XTA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25F6XTA worth?
The government has obligated $41,372 on SPE2DX25F6XTA.
Is contract SPE2DX25F6XTA an order under another contract?
Yes. SPE2DX25F6XTA is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTA competed?
The extent of competition for SPE2DX25F6XTA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award